Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-human Trial of the Coronavirus Virus-like Particle Subunit Vaccine ABNCoV2 in SARS-CoV-2-naïve Adult Volunteers in Good Health

NCT04839146 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04839146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04839146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-human Trial of the Coronavirus Virus-like Particle Subunit Vaccine ABNCoV2 in SARS-CoV-2-naïve Adult Volunteers in Good Health
Lead sponsor
Radboud University Medical Center
Phase
Phase 1
Overall status
Completed
Start date
March 11, 2021
Completion date
February 25, 2022
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars-cov-2 infection, severe acute respiratory syndrome